In an analysis of a French cohort of patients with CKD not receiving erythropoiesis stimulating agents, anaemia is more ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

For decades, recruitment has been built on a familiar ritual. A vacancy opens. Candidates are invited to apply. CVs pour in.

After years of construction and millions of dollars, the long-awaited CV Link is officially open — a 40-mile path stretching ...

Semaglutide therapy was associated with higher likelihood of passing low-risk cardiovascular thresholds among patients with ...

CV retail sales showed off strong YoY, MoM and YTD sales growth while sales are set to improve during the ongoing marriage ...

This year has seen 93 CVs reported as having been launched, closed or being mulled by GPs, according to the Q1-Q3 2025 ...

Following the approvals from exchanges, Tata Motors had informed in an exchange filing this week that its CV business will ...

Motilal Oswal remains 'Neutral' on the stock, with a target price of Rs 341 apiece. This implies an upside potential of more ...

As Tata Motors' demerged commercial vehicle arm (TMCV) gears up for its November 12 listing, analysts stay bullish on CV ...